Ernexa Therapeutics Announces Oral Presentation at the 67th American Society of Hematology (ASH) Annual Meeting
Ernexa Therapeutics Strengthens Scientific and Medical Advisory Board with Appointment of Leading Oncologist Dr. Ira S. Winer, M.D., Ph.D., FACOG
Ernexa Therapeutics to Present at Oxford Global's Cell 2025 [Yahoo! Finance]
Ernexa Therapeutics to Present at Oxford Global’s Cell 2025
Ernexa Therapeutics Reports Strong Quarterly Performance, Highlighting Operational Execution and Progress Toward First-in-Human Cell Therapy Trials [Yahoo! Finance]